First Biosimilar Medication Earns U.S. FDA Approval

On March 6, 2015, Zarxio™ (filgrastim-sndz), which is manufactured by Sandoz, was the first biosimilar medication to receive approval by the U.S. Food and Drug Administration (FDA). Zarxio is biosimilar to Neupogen®, which is manufactured by Amgen. However, these two...